Latest Model Sars-cov-2 3clpro/3c-like Protease Protein (a191t) (cov-ve0lg) For A Limited Time [rub89LA5]

SARS-CoV-2 3CLpro/3C-like Protease Protein (A191T) (COV-VE0LG)

The SARS-CoV-2 3CLpro/3C-like Protease Protein (A191T) (COV-VE0LG) is a cutting-edge research tool designed for virology and pharmaceutical applications. This high-purity protein is meticulously synthesized to provide scientists with a reliable and efficient component for their research endeavors. The A191T mutation enhances the protein's stability and functionality, making it an ideal choice for in-depth studies on the SARS-CoV-2 virus.

• High Purity: The protein is produced through a state-of-the-art biotechnology process, ensuring a purity level that meets the highest industry standards.
• Stable Formulation: The A191T mutation contributes to the protein's stability, allowing for consistent and reliable results across various experimental conditions.

Key Features and Specifications

Our SARS-CoV-2 3CLpro/3C-like Protease Protein (A191T) (COV-VE0LG) boasts several key features that set it apart from other research tools. It is available in a lyophilized form, which simplifies storage and shipping, and ensures long-term stability. Additionally, the protein is fully characterized, providing researchers with comprehensive data for their studies.

• Lyophilized Form:便于储存和运输，减少样品损耗。
• Comprehensive Characterization: 提供详细的蛋白质信息，帮助研究人员进行精确的实验设计。

Practical Applications and Benefits

The SARS-CoV-2 3CLpro/3C-like Protease Protein (A191T) (COV-VE0LG) is an invaluable asset for researchers studying the SARS-CoV-2 virus. It can be used in various applications, including structural biology, drug discovery, and vaccine development. By using this protein, scientists can gain deeper insights into the virus's mechanisms and develop more effective treatments.

• Structural Biology Studies: Assists in understanding the protein's three-dimensional structure, crucial for drug design.
• Drug Discovery: Provides a valuable tool for identifying potential antiviral compounds.